GeneDx Holdings WGS Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's accrued expenses?
- GeneDx Holdings (WGS) reported accrued expenses of $35.95M in Q1 2026.
- How has GeneDx Holdings's accrued expenses changed year-over-year?
- GeneDx Holdings's accrued expenses increased by 46.4% year-over-year, from $24.56M to $35.95M.
- What is the long-term trend for GeneDx Holdings's accrued expenses?
- Over 5 years (2020 to 2025), GeneDx Holdings's accrued expenses has grown at a 10.7% compound annual growth rate (CAGR), from $28.14M to $46.86M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.